Retrospective Multicenter Study Describing Baseline Clinical Characteristics and Outcomes in BLINCYTO® Treated Adult Patients With Relapsed or Refractory B-cell Precursor ALL Stratified by Baseline Disease Burden and Cytoreductive Therapy (20200012) First published 12/10/2020 Last updated 22/01/2025 EU PAS number:EUPAS37395 Study Planned